The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - BD Bard; Ferring; Ipsen; Janssen; Sanofi
Consulting or Advisory Role - BD Bard; Ferring; Ipsen; Janssen; Sanofi
Baseline parameters of patients with prostate cancer (PCa) initiating a triptorelin treatment for at least 12 months in real life, TALISMAN study interim analysis.
 
Antoine Thiery-Vuillemin
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Pfizer; Roche
 
Jerome Rigaud
Honoraria - Astellas Pharma; Intuitive Surgical; Ipsen; Janssen; Recordati; Takeda
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Gilles Crehange
No Relationships to Disclose
 
Nathalie Pello Leprince Ringuet
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Anne-Sophie Grandoulier
Other Relationship - Ipsen (Inst)
 
Thierry Lebret
Honoraria - AstraZeneca; Bayer; Ipsen; Roche
Consulting or Advisory Role - Ipsen